MIT: Building a Better Manufacturing Process for Novartis for $65m

In a Boston Globe article posted today, pharmaceutical giant Novartis announced that it would be contributing $65 million to the Massachusetts Institute of Technology (MIT) over the next 10 years to create a new research program with a goal of improving the current drug manufacturing process with better technology in order to save both time [...]


Tall, Fair and Handsome

Cosmetic pharmaceuticals is an interesting industry to look at in different parts of the world. Sociologically speaking, what people want to look like versus what they do look like appears to play an intricate role in the products that are developed and how they are sold. But what kind of message is being [...]


The Vaccination Debate

I was making myself a snack the other night when I noticed Jenny McCarthy on the TV program my wife happened to be watching. Having not seen her as much in recent years as I did when I was younger, I was curious as to whether she was on a talk show because she [...]


Supplemental Health

Last night, my company sponsored an event for our meetup group where our speaker discussed licensing within a pharmaceutical setting, different types of licensing, and advantages and disadvantages to each. During a discussion about the current state of the pharmaceutical industry, I said there should be more exploration into alternative medicines and dietary-supplements as [...]


Wonder Wheat

You may have been to the supermarket recently and noticed an increase in the price of pasta. One of my college friends once called it the “poor single man’s dinner,” providing a filling meal that was easy to make and easy on the wallet. While still an incredibly inexpensive food and something that [...]


Ethical Dilemma

In my second post ever on this site, I wrote about the FDA Fast Track program called Pay-For-Review, and I questioned whether drug companies who took advantage of this program were being given enough scrutiny for the products they were putting to market. Interestingly, in a Boston Globe article yesterday called “Burden of Proof,” [...]


Vioxx Litigation Update

Some of my earliest posts for this blog explored the legal battles that face many pharmaceuticals today because of the proven dangers of their drugs that were not fully disclosed at the time the drugs were released into the market. I spoke of Vioxx, Zelnorm and Celebrex, though they were certainly not the only [...]


The Personal Range Finder

Today’s blog comes to us from Justin Downs, a student at the Interactive Telecommunications Program (ITP) in the Tisch School of the Arts at New York University. Justin has a broad range of talents that he’s explored since getting his Bachelor’s degree at the School of Visual Arts in New York in 2002, including [...]